Toxic RNA exposure, not repeat growth, may drive worsening DM1 heart disease

Myotonic dystrophy type 1 (DM1) is the most common cause of adult-onset muscular dystrophy, a genetic disorder that leads to muscle weakness and wasting, but also affects the brain, the ...
News Medical

Toxic RNA drives progressive heart damage in myotonic dystrophy

Myotonic dystrophy type 1 (DM1) is the most common cause of adult-onset muscular dystrophy, a genetic disorder that leads to muscle weakness and wasting, but also affects the brain, the ...
ET HealthWorld

MUSCULAR DYSTROPHY

ETHealthworld.com brings latest muscular dystrophy news, views and updates from all top sources for the Indian Health ...
Medindia on MSN

Hidden Heart Risks in Muscular Dystrophy: Why Early Action Matters

India, April 5 -- Myotonic dystrophy type 1 (DM1) is the leading form of muscular dystrophy that appears in adulthood. While it is best known for causing progressive muscle weakness and loss, the ...
Business Wire

IND for ATA-100, a Gene Therapy for the Treatment of Limb-Girdle Muscular Dystrophy Type 2I/R9 (LGMD2I/R9), cleared to proceed by FDA

EVRY, France--(BUSINESS WIRE)--Atamyo Therapeutics, a biotechnology company focused on the development of new-generation gene therapies targeting muscular dystrophies and cardiomyopathies, today ...
WCVB Channel 5 Boston

FDA expands approval of first gene therapy for rare form of muscular dystrophy

The U.S. Food and Drug Administration has given the green light for the first gene therapy that treats a rare form of muscular dystrophy to be used in most people who have the disease and a certain ...